Historical record - last NADAC publication: 6/21/2023
Product Information
QC IBUPROFEN 200 MG TABLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.0350 per EA under NDC 63868026825. Its NADAC has been published 24 times since Jan 18, 2023.
Strength
200 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
63868026825
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/21/2023
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA079174On Market Since
5/31/2021
Pharmacological Classes
Price Statistics
The NADAC for QC IBUPROFEN 200 MG TABLET has been published 24 times since Jan 18, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0350 per EA |
|---|---|
| All-time high | $0.0353 (Feb 15, 2023) |
| All-time low | $0.0326 (May 17, 2023) |
| Median price | $0.0335 |
| Average price | $0.0340 |
| Largest weekly change | +7.3% (Jun 21, 2023) |
| Weeks tracked | 24 |
| Tracking since | Jan 18, 2023 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QC IBUPROFEN 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QC IBUPROFEN 200 MG TABLET, manufactured by Chain Drug Marketing Association, is $0.0350 per EA (NDC 63868026825), effective Jun 28, 2023.
How has the price of QC IBUPROFEN 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for QC IBUPROFEN 200 MG TABLET has held within roughly two percent of its current level. It has been tracked across 24 weekly CMS publications since Jan 18, 2023.
What are the highest and lowest recorded NADAC prices for QC IBUPROFEN 200 MG TABLET?
Since Jan 18, 2023, the NADAC for QC IBUPROFEN 200 MG TABLET has ranged from a low of $0.0326 (May 17, 2023) to a high of $0.0353 (Feb 15, 2023), with a median of $0.0335 per EA.
Are there cheaper alternatives to QC IBUPROFEN 200 MG TABLET?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IBUPROFEN 200 MG TABLET, is $0.0269 per EA — about 23% below QC IBUPROFEN 200 MG TABLET.
Who manufactures QC IBUPROFEN 200 MG TABLET?
QC IBUPROFEN 200 MG TABLET (NDC 63868026825) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.
Related Drugs
Same classification